Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:57 PM
Ignite Modification Date:
2025-12-24 @ 3:57 PM
NCT ID:
NCT06190392
Eligibility Criteria:
Inclusion Criteria:
* Age ≥ 18 years
* ED adult patients with suspected pulmonary embolism defined as:
* New onset of or worsening shortness of breath
* Or Chest pain
* Or Syncope in the absence of any obvious other cause (such as pneumothorax, asthma attack, ST elevation myocardial infarction, trauma, etc.)
* Patient able to understand and give oral consent
* Informing and obtaining the patient's oral consent
* Social security affiliation (except AME)
Exclusion Criteria:
* Patients currently treated with full-dose anticoagulant therapy
* Diagnosed thrombo-embolic event in the past 6 months
* PE ruled out by the PERC rule (low clinical probability and none of the 8 items of the PERC score)
* Acute severe presentation (clinical signs of respiratory distress, hypotension, SpO2 \< 90%, shock)
* DDimer level known before ED visit
* Patient living in assisted-living home or nursing home or palliative center. Anticipated life expectancy \< 3 months or "do not resuscitate" order
* Patient under legal protection measure (tutorship or curatorship) and patient deprived of freedom
* Pregnancy and breastfeeding
* Participation in another interventional trial
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06190392
Study Brief:
Protocol Section:
NCT06190392